−0.8 ILS
−20.96 M ILS
0.00 ILS
10.23 M
About EPITOMEE MEDICAL L
Sector
CEO
Dan Hashimshony
Headquarters
Caesarea
Website
Founded
2005
ISIN
IL0011825911
FIGI
BBG0141BJ1R2
Epitomee Medical Ltd. engages in the development of ingestible therapeutic devices. It operates through the Medical Devices for Weight Loss and Medical Devices for the Introduction of Biological Drugs segments. The Medical Devices for Weight Loss segment develops a pill that causes satiety that helps weight loss. The Medical Devices for the Introduction of Biological Drugs segment includes medical devices packaged in capsules and taken by ingestion which are intended for the introduction of biological drugs. The company was founded by Shimon Eckhouse and Doron Marco on August 15, 2005 and is headquartered in Caesarea, Israel.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of EPIT is 935.4 ILA — it has increased by 4.41% in the past 24 hours. Watch EPITOMEE MEDICAL L stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TASE exchange EPITOMEE MEDICAL L stocks are traded under the ticker EPIT.
EPIT stock has fallen by −1.75% compared to the previous week, the month change is a 2.12% rise, over the last year EPITOMEE MEDICAL L has showed a −36.71% decrease.
EPIT reached its all-time high on Dec 15, 2021 with the price of 5,300.0 ILA, and its all-time low was 249.4 ILA and was reached on Aug 12, 2024. View more price dynamics on EPIT chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
EPIT stock is 5.08% volatile and has beta coefficient of −2.64. Track EPITOMEE MEDICAL L stock price on the chart and check out the list of the most volatile stocks — is EPITOMEE MEDICAL L there?
Today EPITOMEE MEDICAL L has the market capitalization of 270.21 M, it has decreased by −4.20% over the last week.
Yes, you can track EPITOMEE MEDICAL L financials in yearly and quarterly reports right on TradingView.
EPIT net income for the last half-year is −19.83 M ILS, while the previous report showed −2.53 M ILS of net income which accounts for −683.73% change. Track more EPITOMEE MEDICAL L financial stats to get the full picture.
No, EPIT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, EPIT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EPITOMEE MEDICAL L stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So EPITOMEE MEDICAL L technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating EPITOMEE MEDICAL L stock shows the buy signal. See more of EPITOMEE MEDICAL L technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.